Korean Post-marketing Surveillance for Xeljanz

CompletedOBSERVATIONAL
Enrollment

1,041

Participants

Timeline

Start Date

May 13, 2016

Primary Completion Date

June 9, 2022

Study Completion Date

June 9, 2022

Conditions
Rheumatoid ArthritisPsoriatic Arthritis
Trial Locations (49)

10475

Myongji Hospital / Rheumatology, Goyang-si

13496

CHA Bundang Medical Center, Seongnam-si

13620

Seoul National University Bundang Hospital, Seongnam-si

24253

Hallym University Chuncheon Sacred Heart Hospital, Chuncheon

28644

Chungbuk National University Hospital, Chungcheongbuk-do

35365

Kongyang University Hospital / Rheumatology, Seogu

47392

Inje University Busan Paik hospital, Busan

50612

Pusan National University Yangsan Hospital, Yangsan

Yangsan Hospital-Pusan National University, Yangsan

61453

Chosun University Hospital, Rheumatism Department, Donggu

570711

Wonkwang University Hospital / Division of Rheumatology, Iksan

330-721

Soonchunhyang University Cheonan Hospital, Department of Rheumatology, Chunan-si

700-712

Keimyung University Dongsan Medical Center, Jung-Gu

05278

Kyung Hee University Hospital at Gangdong / Rheumatology, Seoul

05367

VHS Medical Center / Rheumatologist, Seoul

Unknown

Division of Rheumatology, Seongnam-si

Korea University Ansan Hospital, Ansan, Gyeonggi-do

Yongin Severance Hospital, Giheung-gu, Yongin-si, Gyeonggi-do

Inje University IlsanPaik Hospital, Goyang-si, Gyeonggi-do

Dongguk University Ilsan Medical Center, Gyeonggi-do

Division of Rheumatology, Incheon

Jeju National University Hospital, Jeju Special Self-Goverming Province

Division of Rheumatology, Metropolitan City, Daejeon

Dong-A University Hospital, Pusan

Division of Rheumatology, Seoul

Ewha Womans University Mokdong Hospital, Seoul

Hallym University Kangnam Sacred Heart Hospital, Seoul

Kyung Hee University Medical Center, Seoul

561-712

Chonbuk National University Hospital, Department of Rheumatology, Jeonju

442-712

Ajou University Hospital, Department of Rheumatology, Suwon

607-702

Kosin University Gospel Hospital, Busan

612-896

Inje University Haeundae Paik Hospital, Busan

705-718

Daegu Catholic University Medical Center, Department of Rheumatology, Daegu

302-799

Eulji University Hospital, Internal Medicine, Rheumatology, Daejeon

405-760

Gachon University Gil Hospital, Incheon

602-739

Pusan National University Hospital, Pusan

04782

Hanyang Rheuma Uhm Wan-Sik Clinic, Seoul

07061

Division of Rheumatology, SMG-SNU Boramae Medical Center, Seoul

110-744

Seoul National University Hospital, Department of Internal Medicine, Seoul

Seoul National University Hospital, Rheumatology, Internal Medicine, Seoul

130-872

Kyung Hee University Hospital, Seoul

133-792

Hanyang University Hospital, Department of Rheumatology, Seoul

134-890

Kyunghee University East-West Neo Medical Center, 149 Sangil-dong, Gangdong-gu, Seoul

135-710

Samsung Medical Center, Division of Rheumatology, Department of Medicine, Seoul

137-701

The Catholic University of Korea, Kangnam St. Mary's Hospital/ Rheumatology, Internal Medicine, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital/ Rheumatology, Internal Medicine, Seoul

139-711

Eulji Medical Center, Seoul

140-887

Soonchunhyang University Hospital Seoul/Department of Rheumatology, Seoul

143-729

Konkuk University Medical Center, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02984020 - Korean Post-marketing Surveillance for Xeljanz | Biotech Hunter | Biotech Hunter